GSK Biologicals Meningococcal Vaccine 134612
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK Biologicals Meningococcal Vaccine 134612, covering 2016-10-25 to 2016-10-25. Get the full timeline:
Most recent: Clinical Trial Update: Study in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612 [Phase 2]